Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Quercus agrifolia pollen
- Development stage
- Unknown
- Lead developer
- ALK Abelló
- Modality
- Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Percutaneous, Intradermal
01
Overview
Quercus agrifolia pollen is an allergenic extract from the pollen of the California live oak (Quercus agrifolia). It is used for both allergy testing and immunotherapy. As a diagnostic tool, it helps identify patients with a clinical history of allergies to this specific pollen. For treatment, it is used in immunotherapy to reduce allergic symptoms in patients with confirmed sensitivity, demonstrated by positive skin tests or specific IgE antibody tests. The product, manufactured by ALK-Abello, Inc., is a non-standardized allergenic extract administered as a subcutaneous injection. It works by inducing hyposensitization. It was first approved in the U.S. in 1968.
- Other names
- California live oak pollencoast live oak pollen
02
Targets
A. annua-specific IgE (Artemisia annua-specific immunoglobulin E)TCR-Que-a (T cell receptor recognizing Quercus agrifolia pollen-derived peptides)
Beyond the preview
Go deeper on Quercus agrifolia pollen.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Quercus agrifolia pollen.